This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Erik Gordon | |
|---|---|
| Name | Erik Gordon |
| Occupation | Professor, consultant, commentator, author |
| Employer | University of Michigan, University of Michigan Ross School of Business |
| Alma mater | Princeton University, University of Pennsylvania, Wharton School |
Erik Gordon is an American business professor, consultant, and media commentator known for work on entrepreneurship, finance, and corporate strategy. He holds a faculty position at the University of Michigan Ross School of Business and has advised startups, venture capitalists, and established firms across technology and healthcare sectors. Gordon frequently appears in national media and writes on topics linking financial markets, innovation, and public policy.
Gordon grew up in the United States and completed undergraduate studies at Princeton University, followed by graduate degrees from the University of Pennsylvania and the Wharton School. His academic training combined elements of finance, accounting, and strategic management at institutions associated with notable scholars such as Michael Jensen, Eugene Fama, and Myron Scholes. During his formative years he engaged with research networks connected to National Bureau of Economic Research and participated in conferences sponsored by American Finance Association and Academy of Management.
Gordon is a professor at the University of Michigan Ross School of Business, where he teaches courses on corporate finance, entrepreneurial finance, and strategic management. His academic appointments include collaborations with faculty from Harvard Business School, Stanford Graduate School of Business, and Columbia Business School through joint seminars and visiting scholar programs. He has supervised doctoral students who later joined departments at institutions such as Northwestern University Kellogg School of Management, University of Chicago Booth School of Business, and Duke University Fuqua School of Business. Gordon has served on curriculum committees linked to the Association to Advance Collegiate Schools of Business and contributed to case collections used by the Case Centre.
In addition to academic work, Gordon has consulted for startups, venture capital firms, and public companies in sectors including biotechnology, information technology, and healthcare services. His client list has involved interactions with organizations like Sequoia Capital, New Enterprise Associates, and corporate development teams from firms such as Pfizer, Intel, and General Electric. He has helped structure financing rounds involving angel investors, venture capital syndicates, and strategic corporate investors, and advised on mergers and acquisitions involving firms tracked by S&P 500 indices. Gordon’s consulting practice has connected him with incubators and accelerators including Y Combinator and university-affiliated technology transfer offices linked to Massachusetts Institute of Technology and University of California, Berkeley.
Gordon is a frequent commentator in national and business media outlets, appearing on programs produced by NPR, Bloomberg Television, CNBC, and contributing op-eds to publications such as The Wall Street Journal, The New York Times, and The Washington Post. He has been interviewed regarding topics including startup financing, corporate governance, and the pharmaceutical industry, providing analysis alongside guests from Brookings Institution, Heritage Foundation, and Hoover Institution. Gordon also participates in podcast interviews produced by outlets like Recode Decode and Planet Money, and speaks at public events hosted by organizations such as TEDx and Aspen Institute.
Gordon’s research spans entrepreneurial finance, corporate valuation, and public policy implications for innovation. His publications appear in journals and outlets connected to Journal of Finance, Harvard Business Review, and industry-focused reviews associated with Clinical Therapeutics and Nature Biotechnology. He has authored case studies distributed through the Harvard Business School Publishing network and contributed chapters to edited volumes published by Oxford University Press and Cambridge University Press. Gordon’s working papers have been presented at meetings of the Financial Management Association and disseminated via working paper series affiliated with the National Bureau of Economic Research.
Gordon has received awards and honors from academic and professional organizations recognizing teaching excellence and impact on practice, including faculty teaching awards at the University of Michigan and citations in practitioner lists compiled by Forbes and Fortune. His commentary and analysis have been cited by policymakers and industry groups such as U.S. Food and Drug Administration advisory panels and trade organizations representing the biotechnology and medical device sectors.
Category:American academics Category:Business school faculty